ASH And ASCO Release Updated Guideline On The Use Of Chemotherapy-Related Anemia Treatments In Cancer Patients

(www.news.mayoclinic.com)The American Society of Hematology (ASH) and the American Society of Clinical Oncology (ASCO) have released an updated joint guideline on the use of erythropoiesis-stimulating agents (ESAs), a class of drugs that stimulate the bone marrow to produce more red blood cells, to treat chemotherapy-related anemia. [click link for full article]